Literature DB >> 20220160

Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Florent Morio1, Delphine Horeau-Langlard, Françoise Gay-Andrieu, Jean-Philippe Talarmin, Alain Haloun, Michelle Treilhaud, Philippe Despins, Frédérique Jossic, Laurence Nourry, Isabelle Danner-Boucher, Sabine Pattier, Jean-Philippe Bouchara, Patrice Le Pape, Michel Miegeville.   

Abstract

We report a case of disseminated Scedosporium/Pseudallescheria infection due to Pseudallescheria boydii sensu stricto after lung transplantation in a patient with cystic fibrosis. Dissemination occurred under voriconazole. Despite surgery and combination therapy with voriconazole, caspofungin, and terbinafine, the patient died 8 months after transplantation. Previously reported cases are reviewed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20220160      PMCID： PMC2863884          DOI： 10.1128/JCM.01840-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  29 in total

1.  Is combination therapy indicated for invasive fungal infections? Yes and no.

Authors:  José G Montoya; Fernando Rosso
Journal:  Curr Opin Infect Dis       Date:  2006-08       Impact factor: 4.915

2.  Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.

Authors:  Fèlix Gilgado; Carolina Serena; Josep Cano; Josepa Gené; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

3.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

Authors:  Shahid Husain; Patricia Muñoz; Graeme Forrest; Barbara D Alexander; Jyoti Somani; Kathleen Brennan; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

4.  Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.

Authors:  Fred Widmer; Lesley C Wright; Daniel Obando; Rosemary Handke; Ranjini Ganendren; David H Ellis; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species.

Authors:  Felix Gilgado; Josep Cano; Josepa Gené; Josep Guarro
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Pseudallescheria boydii infection of the brain: imaging with pathologic confirmation.

Authors:  V Albernaz; B Huston; M Castillo; S Mukherji; T W Bouldin
Journal:  AJNR Am J Neuroradiol       Date:  1996-03       Impact factor: 3.825

7.  Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.

Authors:  J Gavalda; O Len; R San Juan; J M Aguado; J Fortun; C Lumbreras; A Moreno; P Munoz; M Blanes; A Ramos; G Rufi; M Gurgui; J Torre-Cisneros; M Montejo; M Cuenca-Estrella; J L Rodriguez-Tudela; A Pahissa
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

8.  Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

9.  Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.

Authors:  Françoise Symoens; Christiane Knoop; Marc Schrooyen; Olivier Denis; Marc Estenne; Nicole Nolard; Frédérique Jacobs
Journal:  J Heart Lung Transplant       Date:  2006-03-23       Impact factor: 10.247

10.  Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media.

Authors:  C C Blyth; A Harun; P G Middleton; S Sleiman; O Lee; T C Sorrell; W Meyer; S C A Chen
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948
View more
  16 in total

Review 1.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 2.  Ecology of Scedosporium Species: Present Knowledge and Future Research.

Authors:  A Rougeron; S Giraud; A Alastruey-Izquierdo; J Cano-Lira; J Rainer; A Mouhajir; S Le Gal; G Nevez; W Meyer; J P Bouchara
Journal:  Mycopathologia       Date:  2017-09-19       Impact factor: 2.574

3.  Challenges in Laboratory Detection of Fungal Pathogens in the Airways of Cystic Fibrosis Patients.

Authors:  Sharon C-A Chen; Wieland Meyer; Catherine H Pashley
Journal:  Mycopathologia       Date:  2017-06-06       Impact factor: 2.574

4.  Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis.

Authors:  Sara Mina; Agnès Marot-Leblond; Bernard Cimon; Maxime J J Fleury; Gérald Larcher; Jean-Philippe Bouchara; Raymond Robert
Journal:  Clin Vaccine Immunol       Date:  2014-10-29

Review 5.  Impact of multidrug-resistant organisms on patients considered for lung transplantation.

Authors:  Shmuel Shoham; Pali D Shah
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

6.  N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.

Authors:  Michaela Lackner; Ulrike Binder; Martin Reindl; Beyhan Gönül; Hannes Fankhauser; Christian Mair; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

7.  Susceptibility and diversity in the therapy-refractory genus scedosporium.

Authors:  M Lackner; F Hagen; J F Meis; A H G Gerrits van den Ende; D Vu; V Robert; J Fritz; T A A Moussa; G S de Hoog
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

8.  Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient.

Authors:  Christophe Marguet; Loïc Favennec; Olivier Matray; Sébastien Bertout; Sandrine Giraud; Laure Couderc; Rachid Zouhair; Christine Leguillon; Gilles Gargala; Jean-J Jacques Ballet; Jean-Philippe Bouchara
Journal:  Med Mycol Case Rep       Date:  2012-09-12

9.  Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections.

Authors:  Andrés F Henao-Martínez; José R Castillo-Mancilla; Michelle A Barron; Aran Cunningham Nichol
Journal:  Case Rep Infect Dis       Date:  2013-04-29

10.  Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum.

Authors:  B Luijk; M B Ekkelenkamp; P A De Jong; J M Kwakkel-van Erp; J C Grutters; D A van Kessel; E A van de Graaf
Journal:  Case Rep Infect Dis       Date:  2011-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.